Press releases
- Hims & Hers Announces Access to GLP-1 Injections, Passing Cost Savings Onto Customers
- Hims & Hers Welcomes Anja Manuel, Foreign Policy Expert, Domestic Regulations Advisor, and Former Diplomat to its Board of Directors
- Hims & Hers Health, Inc. Reports First Quarter 2024 Financial Results
- Hims & Hers to Announce First Quarter 2024 Financial Results on May 6, 2024
- Hims & Hers Appoints Christopher Payne, Seasoned Tech Industry Executive, as Newest Board Member
- Hims & Hers to Participate in Canaccord Genuity's Virtual eCommerce Sustainable Advantage Forum on March 14, 2024
- Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
More ▼
Key statistics
As of last trade Hims & Hers Health Inc (82W:FRA) traded at 15.73, -13.57% below its 52-week high of 18.20, set on May 20, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 14.46 |
---|---|
High | 15.73 |
Low | 14.46 |
Bid | 15.00 |
Offer | 15.40 |
Previous close | 14.82 |
Average volume | 26.82k |
---|---|
Shares outstanding | 214.79m |
Free float | 179.28m |
P/E (TTM) | -- |
Market cap | 3.40bn USD |
EPS (TTM) | -0.016 USD |
Data delayed at least 15 minutes, as of May 24 2024 16:18 BST.
More ▼